NEOD001

Prothena revives its former lead drug, aiming for a smaller population with more severe cases
Endpoints
Wed, 02/3/21 - 10:59 pm
Prothena
NEOD001
clinical trials
AL amyloidosis
Prothena’s lead drug NEOD001 just imploded in 2 late-stage studies — and there’s nothing left to salvage
Endpoints
Mon, 04/23/18 - 09:14 am
Prothena
AL amyloidosis
clinical trials
NEOD001
Today’s Top Biotech Stories: Horizon Pharma, Prothena, and Portola Pharmaceuticals
Motley Fool
Wed, 03/19/14 - 12:01 pm
Horizon Pharma
Prothena
Portola Pharmaceuticals
M&A
Vidara
NEOD001
andexanet alfa